Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.85 - $15.47 $194,340 - $253,708
-16,400 Reduced 15.86%
87,000 $1.28 Million
Q2 2024

Aug 14, 2024

BUY
$12.93 - $18.45 $667,188 - $952,020
51,600 Added 99.61%
103,400 $1.49 Million
Q1 2024

May 15, 2024

BUY
$14.37 - $16.46 $30,177 - $34,566
2,100 Added 4.23%
51,800 $843,000
Q4 2023

Feb 14, 2024

BUY
$8.6 - $14.94 $183,180 - $318,222
21,300 Added 75.0%
49,700 $740,000
Q3 2023

Nov 15, 2023

SELL
$9.81 - $12.62 $455,184 - $585,568
-46,400 Reduced 62.03%
28,400 $319,000
Q2 2023

Aug 23, 2023

SELL
$8.08 - $10.37 $292,496 - $375,394
-36,200 Reduced 32.61%
74,800 $752,000
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $31,643 - $52,488
3,600 Added 3.35%
111,000 $1.01 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $1,149 - $1,365
-100 Reduced 0.09%
107,400 $1.31 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $878,628 - $2.3 Million
70,800 Added 192.92%
107,500 $1.36 Million
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $70,668 - $95,832
-3,600 Reduced 8.93%
36,700 $734,000
Q1 2022

May 16, 2022

SELL
$24.65 - $29.0 $382,075 - $449,500
-15,500 Reduced 27.78%
40,300 $1.1 Million
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $116,508 - $143,178
4,200 Added 8.14%
55,800 $1.6 Million
Q3 2021

Nov 12, 2021

BUY
$29.2 - $36.72 $657,000 - $826,200
22,500 Added 77.32%
51,600 $1.67 Million
Q2 2021

Aug 06, 2021

BUY
$28.76 - $35.98 $77,652 - $97,145
2,700 Added 10.23%
29,100 $1.03 Million
Q1 2021

May 14, 2021

BUY
$27.85 - $34.49 $735,240 - $910,536
26,400 New
26,400 $760,000
Q3 2020

Nov 13, 2020

SELL
$21.1 - $29.13 $812,350 - $1.12 Million
-38,500 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$18.94 - $24.93 $115,534 - $152,073
6,100 Added 18.83%
38,500 $809,000
Q1 2020

May 11, 2020

BUY
$16.68 - $32.25 $540,432 - $1.04 Million
32,400 New
32,400 $732,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.71B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.